Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Sylvia, DRAZILOVA"'
Autor:
Sylvia Drazilova, Tomas Koky, Marian Macej, Martin Janicko, Dagmar Simkova, Ariunzaya Tsedendamba, Slavomira Komarova, Peter Jarcuska
Publikováno v:
Gastroenterology Insights, Vol 15, Iss 2, Pp 419-432 (2024)
In this review article, we summarize the most common clinical manifestations of Primary biliary cholangitis (PBC): pruritus, fatigue, osteoporosis, and dyslipoproteinemia and discuss their impact of the patients’ quality of life. More than half of
Externí odkaz:
https://doaj.org/article/9cc5e6aa9469492d93be44335f32cb71
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 17 (2024)
Primary biliary cholangitis (PBC) is a chronic autoimmune cholestatic disease characterized by the destruction of the small intrahepatic bile ducts, which can progress to liver cirrhosis. The gold standard in the treatment of PBC is ursodeoxycholic a
Externí odkaz:
https://doaj.org/article/e9910144228f4fc18a263cf2337ac793
Autor:
Sylvia Drazilova, Eduard Veseliny, Patricia Denisa Lenartova, Dagmar Drazilova, Jakub Gazda, Ivica Grgurevic, Martin Janicko, Peter Jarcuska
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2021 (2021)
IgG4-related sclerosing cholangitis, a biliary manifestation of an IgG4-related disease, belongs to the spectrum of sclerosing cholangiopathies which result in biliary stenosis. It presents with signs of cholestasis and during differential diagnosis
Externí odkaz:
https://doaj.org/article/d320906d071c457e86f68c4cbb3fa7b6
Autor:
Jakub Gazda, Martin Janicko, Sylvia Drazilova, Ivica Grgurevic, Tajana Filipec Kanizaj, Tomas Koller, Beatrica Bodorovska, Maja Mijic, Ivana Mikolasevic, Ivana Knezevic Stromar, Branislav Kucinsky, Matej Gazda, Peter Jarcuska
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2021 (2021)
Background. Ursodeoxycholic acid response score (URS) is a prognostic model that estimates the baseline probability of treatment response after 12 months of ursodeoxycholic acid (UDCA) therapy in patients with primary biliary cholangitis (PBC). Aim.
Externí odkaz:
https://doaj.org/article/069badd8a34845328fd1dec40843f2b8
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2021 (2021)
Background. Primary biliary cholangitis (PBC) is a chronic autoimmune cholestatic liver disease with wide ranges of reported incidence and prevalence. Aim. To map the incidence and prevalence of PBC in European countries from 2000 through 2020. Metho
Externí odkaz:
https://doaj.org/article/42cd3ce3c6324e15b82d162977e6e69b
Autor:
Robert Flisiak, Dorota Zarębska-Michaluk, Egle Ciupkeviciene, Sylvia Drazilova, Sona Frankova, Ivica Grgurevic, Bela Hunyady, Peter Jarcuska, Limas Kupčinskas, Michael Makara, Gunita Saulite-Vanaga, Marieta Simonova, Jan Sperl, Ieva Tolmane, Adriana Vince
Publikováno v:
Viruses, Vol 14, Iss 3, p 482 (2022)
In 2016, the WHO announced a plan to eliminate viral hepatitis as a public health threat by 2030. In this narrative review, experts from Bulgaria, Croatia, the Czech Republic, Hungary, Latvia, Lithuania, Poland and Slovakia assessed the feasibility o
Externí odkaz:
https://doaj.org/article/73899e61351e4c9d9d7ca054a09abb60
Autor:
Dagmar Simkova, Jan Mares, Zuzana Vackova, Tomas Hucl, Petr Stirand, Eva Kieslichova, Ondrej Ryska, Julius Spicak, Sylvia Drazilova, Eduard Veseliny, Jan Martinek
Publikováno v:
Surgical Endoscopy. 37:1242-1251
Peroral endoscopic myotomy (POEM) is nowadays a standard method for treatment of achalasia; nevertheless, it remains an invasive intervention with corresponding risk of adverse events (AEs). The classification and grading of AEs are still a matter of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21bd85e5cfc38aa4b47e0aab39d972c3
https://doi.org/10.1007/s00464-022-09621-z
https://doi.org/10.1007/s00464-022-09621-z
Autor:
Sylvia Drazilova, Martin Janicko, Lubomir Skladany, Pavol Kristian, Marian Oltman, Maria Szantova, Dusan Krkoska, Eva Mazuchova, Lubica Piesecka, Veronika Vahalova, Marek Rac, Ivan Schreter, Ladislav Virag, Tomas Koller, Adriana Liptakova, Miriam Ondrasova, Peter Jarcuska
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2018 (2018)
Background and Aims. Chronic hepatitis C is a systemic disease and type 2 diabetes mellitus (T2DM) belongs to more common extrahepatic. The aim of this study was to (i) explore the prevalence of impaired fasting glucose (IFG) and T2DM in patients wit
Externí odkaz:
https://doaj.org/article/df33a1c69b4f4e7892e384221b2e50f3
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2018 (2018)
Patients with chronic hepatitis C have both higher prevalence of diabetes mellitus type 2 (T2DM) and increased cardiovascular risk compared to never infected people. Sustained viral response (SVR) achievement led to decreasing incidence and prevalenc
Externí odkaz:
https://doaj.org/article/5683313100f84aaa9c541bf70764481d
Autor:
Jakub Gazda, Sylvia Drazilova, Matej Gazda, Martin Janicko, Tomas Koky, Marian Macej, Marco Carbone, Peter Jarcuska
Publikováno v:
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
Several ursodeoxycholic acid (UDCA) treatment response definitions have been introduced in primary biliary cholangitis (PBC). However, the lack of a gold standard results in heterogeneity in second-line treatment research and clinical practice.This s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87701d7fed1a965270ae6c89aa93cb2b
https://pubmed.ncbi.nlm.nih.gov/36593158
https://pubmed.ncbi.nlm.nih.gov/36593158